Preface: New Therapeutic Strategies for Prostate Cancer: Reasons for Optimism and Reflection Anthony W. Tolcher Preface Pages: 143 - 144
Targeting Anti-Apoptotic Genes Upregulated by Androgen Withdrawal Using Antisense Oligonucleotides to Enhance Androgen- and Chemo-Sensitivity in Prostate Cancer Martin E. GleaveToby ZellwegerSimon Leung OriginalPaper Pages: 145 - 158
Signaling Inhibitors in the Treatment of Prostate Cancer Gary R. Hudes OriginalPaper Pages: 159 - 172
Endothelin-1 as a Target for Therapeutic Intervention in Prostate Cancer E. Scott KopetzJoel B. NelsonMichael A. Carducci OriginalPaper Pages: 173 - 182
Inhibition of Angiogenesis: Treatment Options for Patients with Metastatic Prostate Cancer William D. FiggErwin A. KrugerWilliam D. Dahut OriginalPaper Pages: 183 - 194
Peroxisome Proliferator-Activated Receptor Gamma (PPARĪ³ as a Novel Target for Prostate Cancer Matthew R. SmithPhilip W. Kantoff OriginalPaper Pages: 195 - 200
New Trial Designs to Assess Antitumor and Antiproliferative Agents in Prostate Cancer Walter Stadler OriginalPaper Pages: 201 - 208
Suramin's Development: What Did we Learn? Maninderjeet KaurEddie ReedWilliam D. Figg OriginalPaper Pages: 209 - 219
Announcement: Call for Mesothelioma Therapy Research Grant Applications Announcement Pages: 221 - 222